[ACRX] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
05-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 9.23%
YoY- -17.75%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 386 475 608 941 265 613 377 1.58%
PBT -15,925 -14,423 -12,731 -12,409 -13,674 -12,558 -12,458 17.76%
Tax 843 885 1,212 3 627 355 -2,601 -
NP -15,925 -14,423 -12,731 -12,412 -13,674 -12,558 -12,458 17.76%
Tax Rate - - - - - - - -
Total Cost 16,311 14,898 13,339 13,353 13,939 13,171 12,835 17.30%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -4,125.65 -3,036.42 -2,093.91 -1,319.02 -5,160.00 -2,048.61 -3,304.51 15.93%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -3.98 -3.63 -3.20 -3.15 -3.47 -3.56 -4.15 -2.74%
EPS Diluted -3.98 -3.63 -3.20 -3.15 -3.47 -3.56 -4.15 -2.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.